CYCLERION THERAPEUTICS INC's ticker is CYCN and the CUSIP is 23255M105. A total of 75 filers reported holding CYCLERION THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $11,265,000 | -35.5% | 10,149 | 0.0% | 0.00% | – |
| Q4 2021 | $17,456,000 | -44.0% | 10,149 | 0.0% | 0.00% | – |
| Q3 2021 | $31,157,000 | -21.3% | 10,149 | 0.0% | 0.00% | – |
| Q2 2021 | $39,581,000 | +39.8% | 10,149 | 0.0% | 0.00% | – |
| Q1 2021 | $28,316,000 | -8.8% | 10,149 | 0.0% | 0.00% | – |
| Q4 2020 | $31,056,000 | -79.2% | 10,149 | -58.8% | 0.00% | – |
| Q3 2020 | $149,665,000 | +2.9% | 24,616 | 0.0% | 0.00% | – |
| Q2 2020 | $145,481,000 | -20.4% | 24,616 | -64.3% | 0.00% | – |
| Q1 2020 | $182,726,000 | +57.1% | 68,953 | +61.3% | 0.00% | – |
| Q4 2019 | $116,277,000 | -99.1% | 42,749 | -95.9% | 0.00% | -100.0% |
| Q3 2019 | $12,609,515,000 | +36.7% | 1,040,389 | +29.2% | 0.01% | +14.3% |
| Q2 2019 | $9,223,592,000 | – | 805,554 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Slate Path Capital LP | 7,157,601 | $3,105,683 | 0.15% |
| Artal Group S.A. | 2,779,122 | $1,206 | 0.07% |
| MFN Partners Management, LP | 3,389,215 | $1,470,580 | 0.07% |
| Intrinsic Value Partners, LLC | 43,105 | $18,703 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 115,000 | $49,899 | 0.00% |
| Penobscot Investment Management Company, Inc. | 10,000 | $4,339 | 0.00% |
| COLONY GROUP LLC | 102,884 | $44 | 0.00% |
| CAPTRUST FINANCIAL ADVISORS | 292,645 | $126,979 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 592,237 | $256,971 | 0.00% |
| STATE STREET CORP | 115,414 | $50,078 | 0.00% |